Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi

özdel, kadir; kart, ayşegül; Turkcapar, Mehmet Hakan

doi:10.29399/npa.27419

Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi

Kadir ÖZDEL, (Sağlık Bilimleri Üniversitesi, Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Psikiyatri Kliniği, Ankara, Türkiye)

Ayşegül KART, (Bakırköy Ruh ve Sinir Hastalıkları Hastanesi, Psikiyatri Kliniği, İstanbul, Türkiye)

Mehmet Hakan TÜRKÇAPAR (Ankara Sosyal Bilimler Üniversitesi, Psikoloji Bölümü, Ankara, Türkiye)

Nöropsikiyatri Arşivi

58 14

Yıl: 2021 Cilt: 58 Sayı: 1 Sayfa Aralığı: 66 - 76 Metin Dili: Türkçe DOI: 10.29399/npa.27419 İndeks Tarihi: 30-12-2021

Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi

Öz:

Bipolar Bozukluk (BB) biyo-psiko-sosyal yaklaşımla ele alınırken ”biyo” vurgusunun ön planda olduğu bir hastalıktır. Ancak hastalık belirtilerinin, birbirinden farklı atak dönemlerinin özelliklerinden dolayı ilaç tedavisiyle idaresi zor olan ve çoğu zaman sadece ilaç tedavisinin yetersiz kaldığı bir durumdur. Görülme sıklığı ve ilaç tedavilerinin yetersizliği düşünüldüğünde BB’nin tedavisinde psikososyal müdahalelerin önemi inkâr edilemez. Ayrıca tedavi uyumsuzluğu da psikososyal olarak ele alınması gereken bir başka sorundur. Psikososyal müdahaleler arasında, Bilişsel Davranışçı Terapi (BDT), deneysel ve esnek olması gibi birçok özelliğiyle eşsiz bir yere sahiptir ve akut mani dönemi dışındaki dönemlerde kanıta dayalı bir güçlendirici tedavi olarak önerilir. Bu gözden geçirmede BDT ile ilgili kanıtlara genel bir bakıştan sonra BDT yöntemlerinin hangi durumlarda nasıl kullanıldığıyla ilgili ayrıntılara yer verilmiştir. Bilişsel davranışçı perspektiften pragmatik bir yaklaşımla BB’de psikoterapi uygulamasının temel esaslarına odaklanılmıştır.

Anahtar Kelime:

Cognitive Behavioral Therapy in Treatment of Bipolar Disorder

Öz:

Biological underpinnings (i.e.,”bio” of bio-psycho-social approach) of Bipolar Disorder (BD) has comparatively been more prominent when addressing to its etiology and treatment. Medical management of the disorder is usually difficult because of significant shortcomings of drug treatment and heterogeneity of symptoms and episodes with opposing features. Taking together the prevalence of BD and shortcomings of drug treatment, psychosocial interventions have undeniable importance in the treatment of the disorder. Another issue one must take into account is lack of treatment adherence. Cognitive Behavioral Therapy (CBT) has its unique position among psychosocial interventions with its features like being empirical and flexible. Accordingly, it is recommended as an adjuvant therapy in every stage of the disorder except acute mania. In this review, after generally addressing the evidence for CBT in BD, we discussed on how it is used in specific areas of the disorder. We focused on essentials of psychotherapy practice with a pragmatic approach from CBT point of view.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Provencher MD, Hawke LD, Thienot E. Psychotherapies for comorbid anxiety in bipolar spectrum disorders. J Affect Disord 2011;133:371–380.
2. World Health Organisation (WHO). International Classification of Diseases and Related Health Problems (ICD)-10; 2010. https://www.who.int/ classifications/icd/ICD10Volume2_en_2010.pdf
3. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders (DSM-5®): American Psychiatric Pub; 2013. https://www. psychiatry.org/psychiatrists/practice/dsm
4. Rihmer Z, Angst J. Duygudurum Bozuklukları: Epidemiyoloji. Aydın H, Bozkurt A (Çev. Ed.). Türkçe: Kaplan & Sadock’s Comprehensive Text Book of Psychiatry 2007;8:1575–1582.
5. Michalak EE, Yatham LN, Lam RW. Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes 2005;3:72.
6. Bauer M, Andreassen OA, Geddes JR, Vedel Kessing L, Lewitzka U, Schulze TG, Vieta E. Areas of uncertainties and unmet needs in bipolar disorders: clinical and research perspectives. Lancet Psychiatry 2018;5:930–939.
7. Fountoulakis KN, Vieta E, Young A, Yatham L, Grunze H, Blier P, Moeller HJ, Kasper S. The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: Unmet Needs in the Treatment of Bipolar Disorder and Recommendations for Future Research. Int J Neuropsychopharmacol 2017;20:196–205.
8. Jauhar S, McKenna PJ, Laws KR. NICE guidance on psychological treatments for bipolar disorder: searching for the evidence. Lancet Psychiatry 2016;3:386–388.
9. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O’Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD)2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018;20:97– 170.
10. Colom F, Vieta E. Psychoeducation manual for bipolar disorder: Cambridge University Press; 2006.
11. Parikh SV, Zaretsky A, Beaulieu S, Yatham LN, Young LT, Patelis-Siotis I, Macqueen GM, Levitt A, Arenovich T, Cervantes P, Velyvis V, Kennedy SH, Streiner DL. A randomized controlled trial of psychoeducation or cognitivebehavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]. J Clin Psychiatry 2012;73:803– 810.
12. Szentagotai A, David D. The efficacy of cognitive-behavioral therapy in bipolar disorder: a quantitative meta-analysis. J Clin Psychiatry 2010;71:66– 72.
13. Chiang K-J, Tsai J-C, Liu D, Lin C-H, Chiu H-L, Chou K-R. Efficacy of cognitivebehavioral therapy in patients with bipolar disorder: A meta-analysis of randomized controlled trials. PloS one 2017;12:e0176849.
14. Xuan R, Li X, Qiao Y, Guo Q, Liu X, Deng W, Hu Q, Wang K, Zhang L. Mindfulness-based cognitive therapy for bipolar disorder: A systematic review and meta-analysis. Psychiatry Res 2020;290:113116.
15. First MB. Structured clinical interview for the DSM (SCID). The Encyclopedia of Clinical Psychology. Wiley Online Library; 2015. p.1–6.
16. Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The MiniInternational Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22–33. https://pubmed.ncbi.nlm. nih.gov/9881538/
17. Beck AT, Ward C, Mendelson M, Mock J, Erbauch J. Beck depression inventory (BDI). Arch Gen Psychiatry 1961;4:561–571.
18. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429–435.
19. Covin R, Dozois DJ, Ogniewicz A, Seeds PM. Measuring cognitive errors: Initial development of the Cognitive Distortions Scale (CDS). Int J Cogn Ther 2011;4:297–322.
20. Weissman A, Beck A. Development and validation of the Dysfunctional Attitudes Scale Paper presented at the meeting of the Association for the Advancement of Behavior Therapy. Chicago, IL; 1978.
21. Allan S, Gilbert P. A social comparison scale: Psychometric properties and relationship to psychopathology. Pers Individ Dif 1995;19:293–299.
22. Ozcelik HS, Ozdel K, Bulut SD, Orsel S. The reliability and validity of the Turkish version of the Beck Scale for Suicide Ideation (Turkish BSSI). Clin Psychopharmacol B 2015;25:141–150.
23. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979;47:343–352.
24. Beier H, Hanfmann E. Emotional attitudes of former Soviet citizens, as studied by the technique of projective questions. J Abnorm Psychol 1956;53:143– 153.
25. Chu CS, Stubbs B, Chen TY, Tang CH, Li DJ, Yang WC, Wu CK, Carvalho AF, Vieta E, Miklowitz DJ, Tseng PT, Lin PY. The effectiveness of adjunct mindfulnessbased intervention in treatment of bipolar disorder: A systematic review and meta-analysis. J Affect Disord 2018;225:234–245.
26. Simon GE, Ludman EJ, Bauer MS, Unützer J, Operskalski B. Long-term effectiveness and cost of a systematic care program for bipolar disorder. Arch Gen Psychiatry 2006;63:500–508.
27. Miller WR, Rollnick S. Motivational interviewing: Helping people change, 3rd ed. Guilford Press; 2012.
28. Otto MW, Reilly-Harrington N, Sachs GS. Psychoeducational and cognitivebehavioral strategies in the management of bipolar disorder. J Affect Disord 2003;73:171–181.
29. Burns DD, Nolen-Hoeksema S. Coping styles, homework compliance, and the effectiveness of cognitive-behavioral therapy. J Consult Clin Psychol 1991;59:305–311.
30. Dimidjian S, Barrera Jr M, Martell C, Muñoz RF, Lewinsohn PM. The origins and current status of behavioral activation treatments for depression. Annu Rev Clin Psychol 2011;7:1–38.
31. Depue RA, Krauss SP, Spoont MR. A two-dimensional threshold model of seasonal bipolar affective disorder. In: Magnusson D, Öhman A, editors. Psychopathology: An interactional perspective (Personality, Psychopathology, and Psychotherapy), 1st ed. Academic Press; 1987. p.95–123.
32. Türkçapar H. Depresyon; Klinik uygulamalarda bilişsel davranışçı terapi. Ankara: HYB Basım Yayın 2009.
33. Melo MCA, Daher EDF, Albuquerque SGC, de Bruin VMS. Exercise in bipolar patients: a systematic review. J Affect Disord 2016;198:32–38.
34. Gray SM, Otto MW. Psychosocial approaches to suicide prevention: applications to patients with bipolar disorder. J Clin Psychiatry 2001;62(Suppl 25):56–64. https://pubmed.ncbi.nlm.nih.gov/11765098/
35. Lovas DA, Schuman-Olivier Z. Mindfulness-based cognitive therapy for bipolar disorder: A systematic review. J Affect Disord 2018;240:247–261.
36. Holmes EA, Arntz A, Smucker MR. Imagery rescripting in cognitive behaviour therapy: Images, treatment techniques and outcomes. J Behav Ther Exp Psychiatr 2007;38:297–305.
37. Michl LC, McLaughlin KA, Shepherd K, Nolen-Hoeksema S. Rumination as a mechanism linking stressful life events to symptoms of depression and anxiety: Longitudinal evidence in early adolescents and adults. J Abnorm Psychol 2013;122:339–352.
38. Beck AT, Haigh EA. Advances in cognitive theory and therapy: The generic cognitive model. Annu Rev Clin Psychol 2014;10:1–24.
39. Beck AT, Warman DM. Cognitive insight: theory and assessment. In: Amador XF, David AS, editors. Insight and psychosis: Awareness of illness in schizophrenia and related disorders, 2nd ed. 2004;2:79–88.
40. Tarrier N, Taylor K, Gooding P. Cognitive-behavioral interventions to reduce suicide behavior: a systematic review and meta-analysis. Behav Modif 2008;32:77–108.
41. McEvoy PM, Hyett MP, Ehring T, Johnson SL, Samtani S, Anderson R, Moulds ML. Transdiagnostic assessment of repetitive negative thinking and responses to positive affect: Structure and predictive utility for depression, anxiety, and mania symptoms. J Affect Disord 2018;232:375–384.
42. Wells A. Metacognitive therapy for anxiety and depression. New York: Guilford Press; 2011.
43. Garno JL, Goldberg JF, Ramirez PM, Ritzler BA. Impact of childhood abuse on the clinical course of bipolar disorder. Br J Psychiatry 2005;186:121–125.
44. Hawke LD, Provencher MD, Parikh SV. Schema therapy for bipolar disorder: A conceptual model and future directions. J Affect Disord 2013;148:118–122.
45. Mitchell PB. Bipolar disorder: the shift to overdiagnosis. Can J Psychiatry 2012;57:659–65.
46. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, PosadaVilla J, Sagar R, Wells JE, Zarkov Z. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011;68:241–251.
47. Gitlin MJ, Miklowitz DJ. The difficult lives of individuals with bipolar disorder: A review of functional outcomes and their implications for treatment. J Affect Disord 2017;209:147–154.
48. Raglan GB, Swanson LM, Arnedt JT. Cognitive behavioral therapy for insomnia in patients with medical and psychiatric comorbidities. Sleep Med Clin 2019;14:167–175.

APA	özdel k, kart a, Turkcapar M (2021). Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi. , 66 - 76. 10.29399/npa.27419
Chicago	özdel kadir,kart ayşegül,Turkcapar Mehmet Hakan Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi. (2021): 66 - 76. 10.29399/npa.27419
MLA	özdel kadir,kart ayşegül,Turkcapar Mehmet Hakan Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi. , 2021, ss.66 - 76. 10.29399/npa.27419
AMA	özdel k,kart a,Turkcapar M Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi. . 2021; 66 - 76. 10.29399/npa.27419
Vancouver	özdel k,kart a,Turkcapar M Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi. . 2021; 66 - 76. 10.29399/npa.27419
IEEE	özdel k,kart a,Turkcapar M "Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi." , ss.66 - 76, 2021. 10.29399/npa.27419
ISNAD	özdel, kadir vd. "Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi". (2021), 66-76. https://doi.org/10.29399/npa.27419

APA	özdel k, kart a, Turkcapar M (2021). Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi. Nöropsikiyatri Arşivi, 58(1), 66 - 76. 10.29399/npa.27419
Chicago	özdel kadir,kart ayşegül,Turkcapar Mehmet Hakan Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi. Nöropsikiyatri Arşivi 58, no.1 (2021): 66 - 76. 10.29399/npa.27419
MLA	özdel kadir,kart ayşegül,Turkcapar Mehmet Hakan Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi. Nöropsikiyatri Arşivi, vol.58, no.1, 2021, ss.66 - 76. 10.29399/npa.27419
AMA	özdel k,kart a,Turkcapar M Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi. Nöropsikiyatri Arşivi. 2021; 58(1): 66 - 76. 10.29399/npa.27419
Vancouver	özdel k,kart a,Turkcapar M Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi. Nöropsikiyatri Arşivi. 2021; 58(1): 66 - 76. 10.29399/npa.27419
IEEE	özdel k,kart a,Turkcapar M "Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi." Nöropsikiyatri Arşivi, 58, ss.66 - 76, 2021. 10.29399/npa.27419
ISNAD	özdel, kadir vd. "Bipolar Bozukluk Tedavisinde Bilişsel Davranışçı Terapi". Nöropsikiyatri Arşivi 58/1 (2021), 66-76. https://doi.org/10.29399/npa.27419